Global Fetal Bovine Serum Market Size Study & Forecast, By Application (Drug Discovery, In-vitro Fertilization, Vaccine Production, Cell-based Research, Diagnostics, Others), By End-user (Pharmaceutical & Biotechnology Companies, Contract Research Organiz

Global Fetal Bovine Serum Market Size Study & Forecast, By Application (Drug Discovery, In-vitro Fertilization, Vaccine Production, Cell-based Research, Diagnostics, Others), By End-user (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CRO), Academic and Research Organizations, Others), and Regional Analysis, 2023-2030

Global Fetal Bovine Serum Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Fetal bovine serum (FBS), also referred to as fetal calf serum (FCS), serves as an indispensable ingredient in the media for cell culture, facilitating the cultivation of cells outside their natural environment in vitro. It is obtained from the blood of bovine fetuses harvested at slaughterhouses. FBS contains an abundance of growth factors, hormones, proteins, and other vital nutrients necessary for cell growth and maintenance. Moreover, the increasing investments in life sciences research, expansion of the biopharmaceutical industry, and rising demand for biologics are anticipated to create a lucrative demand for the market during the forecast period 2023-2030.

Additionally, the growing biopharmaceutical industry plays a significant role in supporting the growth of the fetal bovine serum (FBS) market. Biopharmaceutical companies rely heavily on cell culture techniques for the development and production of therapeutic proteins, vaccines, and cell-based therapies. FBS serves as a critical supplement in cell culture media, providing essential nutrients, growth factors, and hormones necessary for the growth and proliferation of cells. As the biopharmaceutical industry expands and innovates, the demand for FBS increases proportionally. According to Statista, in 2020, the global biopharmaceuticals market was valued at USD 291.4 billion; in 2022 the market reached USD 403.1 billion, and it is anticipated to reach USD 570.1 billion by 2025. As a result, the growing biopharmaceuticals industry is anticipated to create a lucrative opportunity for the market. Moreover, the growing biotechnology and pharmaceutical industries and the rise in R&D investments are anticipated to create a lucrative opportunity for the market. However, the high cost and chances of contamination, and the increase in the use of alternatives stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Fetal Bovine Serum Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing biopharmaceutical research and development, increasing demand for vaccines, rising prevalence of chronic diseases, continuous advancements in cell culture techniques, and supportive regulatory environment in the region. Whereas the Asia Pacific is expected to grow with the fastest growth rate during the forecast period, owing to factors such as the increasing funding for life sciences research, rising investments in bioprocessing infrastructure, growing biotechnology and life sciences industry, expansion of academic and research institutions, and increasing awareness and adoption of cell culture technologies in the region.

Major market players included in this report are:
Thermo Fisher Scientific Inc.
Sartorius AG
Danaher Corporation
Merck KGaA
HiMedia Laboratories
Bio-Techne Corporation
PAN-Biotech GmbH
Atlas Biologicals, Inc.
Rocky Mountain Biologicals
Biowest

Recent Developments in the Market:
 In December 2021, Thermo Fisher, Inc. completed the acquisition of PPD, Inc., a leading U.S.-based provider of clinical research services catering to the pharmaceutical and biotechnology sectors. With this strategic move, Thermo Fisher aims to bolster its portfolio and provide expanded and enhanced services to its biotechnology and pharmaceutical clientele. As a result, the expanded offerings and enhanced services are likely to support the growth of the Fetal Bovine Serum Market by facilitating more efficient and effective research and development processes within the pharmaceutical and biotechnology industries.

Global Fetal Bovine Serum Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Application, End-user, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Application:
Drug Discovery
In-vitro Fertilization
Vaccine Production
Cell-based Research
Diagnostics
Others

By End-user:
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic And Research Organizations
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of the Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.